White label ELPA - ClinicalTrials.eu

Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

Not recruiting

3 1
Investigated Diseases:
Reduced Dose Prasugrel Monotherapy After Stent Placement in Patients with Acute and Chronic Coronary Syndrome

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic coronary syndrome
- Acute coronary syndrome
Investigated Drugs:
- Prasugrel
Study on the Effects of Tebapivat and AG-946 in Patients with Sickle Cell Disease

Not recruiting

2 1
Investigated Diseases:
- Sickle cell disease
Investigated Drugs:
- Ag-946 Phosphate
Study on the Safety and Effects of GSK4418959 and Dostarlimab for Adults with Colorectal Cancer with Mismatch Repair Deficiency or High Microsatellite Instability

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer
- Neoplasm
Investigated Drugs:
- GSK4418959A
- Dostarlimab
Effectiveness and Safety of Rezafungin in Adults with Chronic Pulmonary Aspergillosis Who Have Limited Treatment Options

Not recruiting

2 1 1 1
Investigated Diseases:
- Bronchopulmonary aspergillosis
Investigated Drugs:
- Rezafungin Acetate
+2
Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Not recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Risankizumab
- Vedolizumab
+14
Study of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis

Not recruiting

2 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Sodium Chloride
Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

Not recruiting

3 1 1
Investigated Drugs:
- Empasiprubart
- Human Normal Immunoglobulin (Iv)
+13
Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Not recruiting

3 1 1
Investigated Drugs:
- Ziltivekimab
+1
Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Not recruiting

3 1
Investigated Drugs:
- Rocatinlimab
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies